Speakers

Models of Cancer Therapies Laboratory at the Vall d'Hebron Institute of Oncology (VHIO)

Dr. Laura Soucek

Dr. Laura Soucek is the principal investigator of the Models of Cancer Therapies Laboratory at the Vall d'Hebron Institute of Oncology (VHIO), Co-Founder and Chief Executive Officer (CEO) of Peptomyc S.L., Associate Professor at Universitat Autónoma de Barcelona (UAB) and ICREA Research Professor.

Her remarkable scientific career and research on Myc oncoprotein and its inactivation by inhibitory cell-penetrating miniproteins for cancer treatments have been recognized trough several prestigious national and international grants (FERO fellowship, ERC Consolidator grant, two ERC Proof of Concept grants and a Worldwide Cancer Research grant), making her a leading figure in that field.

In 1998, when she was still an undergraduate student, she designed Omomyc, which has been recently approved by the Spanish Agency of Medicines and Medical Devices (AEMPS) to be tested in the first-in-human Phase I/II clinical trial. It currently emerges as the first disruptive Myc inhibitor preventing tumor growth in a safe way, only causing mild and reversible side effects.

ORGANIZERS